Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin added to metformin in adults with type 2 diabetes mellitus
IRCT20191209045671N1Phase 4Completed
- Sponsor
- Dr. Abidi Pharmaceuticals
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of sitagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Dr. Abidi Pharmaceuticals. Primary endpoints: Blood sugar, Low-density lipoprotein cholesterol and 6 more. Started Nov 2020; status: completed.
02
Drugs
sitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20191209045671N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191209045671N1.